Corcept Therapeutics Inc (NASDAQ:CORT) - Share price - Overview

Stock Report

Corcept Therapeutics Inc CORT

Last Price
$8.65

Day Change
0.14|1.65%

As of 23/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close8.51
Day Range8.37 - 8.73
Mkt Cap960.40Mil
52-Wk Range3.52 - 10.00
Yield %-
ISINUS2183521028
Volume895,595
P/E216.25
P/S13.26
P/CF54.68

Share Price

Financials
201320142015
More ...
Income Statement
Revenue10.3626.5550.29
Operating Income-41.50-27.62-3.44
Net Income-46.01-31.38-6.41
Basic EPS-0.46-0.31-0.06
Avg. Diluted Shares Outstanding100101107
Balance Sheet
Current Assets58.3130.2348.98
Non Current Assets4.774.402.96
Total Assets63.0834.6351.94
Current Liabilities12.7413.5620.88
Total Liabilities42.0638.0233.44
Total Equity21.02-3.3918.50
Cash Flow
Operating Cash Flow-37.06-27.383.13
Capital Expenditure-0.13-0.17-0.02
Free Cash Flow-37.19-27.553.11

In millions, except "Basic EPS". Currency is USD.

Company Profile

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

83
Key Stats
More ...
Price/Earning TTM212.75
Price/Book30.24
Price/Sales TTM13.35
Rev Growth (3 year avg)147.74
EPS Growth (3 year avg)-
Operating Margin % TTM-6.85
Net Margin % TTM-12.74
ROE TTM-84.82
Debt/Equity0.68
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.